SINGAPORE, Dec 16, 2021 - (ACN Newswire) - - Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group ...
CHICAGO, July 16 (Reuters) - An experimental Alzheimer's disease drug developed by Acumen Pharmaceuticals targeting a novel form of the toxic protein beta amyloid in the brain passed an early safety ...
Homegrown medical technology company, Acumen Diagnostics Pte. Ltd., a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited and 49% owned by Aoxin Q&M Dental Group Limited, announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results